$15M funding aims to advance stem cell therapies for petsJanuary 8, 2024The financing will go toward achieving the conditional U.S. Food and Drug Administration (FDA) approval of Gallant Therapeutic’s candidate for feline chronic gingivostomatitis
SPONSORED CONTENTMore life to love for patients with certain types of canine CHF. See how different formulations help dog owners manage certain types of CHF in their pets. + Learn More